Cirrhotic patients on proton pump inhibitors are at a twofold risk of spontaneous bacterial peritonitis independently of gastrointestinal bleeding: a population-based retrospective study
暂无分享,去创建一个
Imad Asaad | A. Almomani | A. Hitawala | Prabhat Kumar | Somtochukwu Onwuzo | Romy Rahhal | Antoine Boustany | Tara Boustany | A. Boustany
[1] Imad Asaad,et al. Epidemiology and prevalence of lean nonalcoholic fatty liver disease and associated cirrhosis, hepatocellular carcinoma, and cardiovascular outcomes in the United States: a population‐based study and review of literature , 2022, Journal of gastroenterology and hepatology.
[2] Prabhat Kumar,et al. Prevalence of hypothyroidism and effect of thyroid hormone replacement therapy in patients with non-alcoholic fatty liver disease: A population-based study , 2022, World journal of hepatology.
[3] G. S. Kew,et al. An Epidemiological Meta-Analysis on the Worldwide Prevalence, Resistance, and Outcomes of Spontaneous Bacterial Peritonitis in Cirrhosis , 2021, Frontiers in Medicine.
[4] M. Boustani,et al. Increasing Economic Burden in Hospitalized Patients With Cirrhosis: Analysis of a National Database , 2019, Clinical and translational gastroenterology.
[5] P. Andersen,et al. Effect of proton pump inhibitors on the risk and prognosis of infections in patients with cirrhosis and ascites , 2019, Liver international : official journal of the International Association for the Study of the Liver.
[6] S. Marciano,et al. Spontaneous bacterial peritonitis in patients with cirrhosis: incidence, outcomes, and treatment strategies , 2019, Hepatic medicine : evidence and research.
[7] M. Manns,et al. Dose‐dependent impact of proton pump inhibitors on the clinical course of spontaneous bacterial peritonitis , 2018, Liver international : official journal of the International Association for the Study of the Liver.
[8] A. Waness,et al. Increased Risk of Spontaneous Bacterial Peritonitis in Cirrhotic Patients Using Proton Pump Inhibitors , 2018, GE - Portuguese Journal of Gastroenterology.
[9] T. Shizuma. Spontaneous bacterial and fungal peritonitis in patients with liver cirrhosis: A literature review , 2018, World journal of hepatology.
[10] T. Woreta,et al. Mortality from Spontaneous Bacterial Peritonitis Among Hospitalized Patients in the USA , 2018, Digestive Diseases and Sciences.
[11] C. Tovo,et al. Influence of proton pump inhibitors in the development of spontaneous bacterial peritonitis , 2017, World journal of hepatology.
[12] D. Rockey,et al. Trends in Hospitalization, Acute Kidney Injury, and Mortality in Patients With Spontaneous Bacterial Peritonitis , 2017, Journal of clinical gastroenterology.
[13] K. Koh,et al. Proton pump inhibitors do not increase the risk for recurrent spontaneous bacterial peritonitis in patients with cirrhosis , 2017, Journal of gastroenterology and hepatology.
[14] A. Martins,et al. Clinical and microbiological characteristics associated with mortality in spontaneous bacterial peritonitis: a multicenter cohort study , 2016, European journal of gastroenterology & hepatology.
[15] F. Bendtsen,et al. Effect of propranolol on survival in patients with decompensated cirrhosis: a nationwide study based Danish patient registers , 2016, Liver international : official journal of the International Association for the Study of the Liver.
[16] G. Garcia‐Tsao. Current Management of the Complications of Cirrhosis and Portal Hypertension: Variceal Hemorrhage, Ascites, and Spontaneous Bacterial Peritonitis , 2016, Digestive Diseases.
[17] A. Krag,et al. Nonselective β‐blockers do not affect mortality in cirrhosis patients with ascites: Post Hoc analysis of three randomized controlled trials with 1198 patients , 2015, Hepatology.
[18] H B Xu,et al. Proton pump inhibitor use and risk of spontaneous bacterial peritonitis in cirrhotic patients: a systematic review and meta-analysis. , 2015, Genetics and molecular research : GMR.
[19] Y. Tsai,et al. Risk of Spontaneous Bacterial Peritonitis Associated With Gastric Acid Suppression , 2015, Medicine.
[20] F. Barreyro,et al. Proton pump inhibitor therapy does not increase the incidence of spontaneous bacterial peritonitis in cirrhosis: a multicenter prospective study. , 2015, Journal of hepatology.
[21] K. Reddy,et al. Long-term use of antibiotics and proton pump inhibitors predict development of infections in patients with cirrhosis. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[22] J. González-Navajas,et al. Use of proton pump inhibitors decrease cellular oxidative burst in patients with decompensated cirrhosis , 2015, Journal of gastroenterology and hepatology.
[23] S. Bota,et al. Proton Pump Inhibitor Intake neither Predisposes to Spontaneous Bacterial Peritonitis or Other Infections nor Increases Mortality in Patients with Cirrhosis and Ascites , 2014, PloS one.
[24] Adrian V. Hernández,et al. Acid‐suppressive therapy is associated with spontaneous bacterial peritonitis in cirrhotic patients: A meta‐analysis , 2013, Journal of gastroenterology and hepatology.
[25] P. Siersema,et al. Bacterial infections in cirrhosis: role of proton pump inhibitors and intestinal permeability , 2012, European journal of clinical investigation.
[26] Anil K. Jain,et al. Association between proton pump inhibitor therapy and Clostridium difficile infection in a meta-analysis. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[27] Stuart J. Nelson,et al. Normalized names for clinical drugs: RxNorm at 6 years , 2011, J. Am. Medical Informatics Assoc..
[28] G. Trikudanathan,et al. Association between proton pump inhibitors and spontaneous bacterial peritonitis in cirrhotic patients – a systematic review and meta‐analysis , 2011, International journal of clinical practice.
[29] A. Burroughs,et al. Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. , 2010, Gastroenterology.
[30] S. Møller. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. , 2010, Journal of hepatology.
[31] R. Hoffmann,et al. Association of Proton Pump Inhibitor Therapy With Spontaneous Bacterial Peritonitis in Cirrhotic Patients With Ascites , 2009, The American Journal of Gastroenterology.
[32] K. Obstein,et al. Association between Proton Pump Inhibitor Use and Spontaneous Bacterial Peritonitis , 2008, Digestive Diseases and Sciences.
[33] M. Navasa,et al. Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis. , 2007, Gastroenterology.
[34] A. Sanyal,et al. Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis , 2007, The American Journal of Gastroenterology.
[35] J. Hoefs,et al. Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club , 2005, Gut.
[36] Miriam C J M Sturkenboom,et al. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. , 2004, JAMA.
[37] M. Navasa,et al. Bacterial infections in cirrhosis: Epidemiological changes with invasive procedures and norfloxacin prophylaxis , 2002, Hepatology.
[38] B. West,et al. Omeprazole Inhibits Phagocytosis and Acidification of Phagolysosomes of Normal Human Neutrophils In Vitro , 2000, Immunopharmacology and immunotoxicology.
[39] R. Fisher,et al. Effect of gastric acid suppressants on human gastric motility , 1998, Gut.
[40] M. Dumont,et al. European Association for the Study of the Liver , 1971 .
[41] S. Schulz,et al. Systematized Nomenclature of Medicine Clinical Terms ( SNOMED CT ) , 2021 .
[42] T. Gustot,et al. Management of bacterial infections in cirrhosis. , 2012, Journal of hepatology.
[43] A. Chotchaeva,et al. [Effect of HP eradication on the development of gastroesophageal reflux disease: results of the prospective study]. , 2011, Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology.
[44] G. D’Amico,et al. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. , 2006, Journal of hepatology.
[45] J. Such,et al. Spontaneous Bacterial Peritonitis , 1997, Seminars in liver disease.